Literature DB >> 16100954

The crystal structure of an engineered monomeric triosephosphate isomerase, monoTIM: the correct modelling of an eight-residue loop.

T V Borchert1, R Abagyan, K V Kishan, J P Zeelen, R K Wierenga.   

Abstract

BACKGROUND: The triosephosphate isomerase (TIM) fold is found in several different classes of enzymes, most of which are oligomers; TIM itself always functions as a very tight dimer. It has recently been shown that a monomeric form of TIM ('monoTIM') can be constructed by replacing a 15-residue interface loop, loop-3, with an eight-residue fragment; modelling suggests that this should result in a short strain-free turn, resulting in the subsequent helix, helix-A3, having an additional turn at its amino terminus.
RESULTS: The crystal structure of monoTIM shows that it retains the characteristic TIM-barrel (betaalpha)8-fold and that the new loop has a structure very close to that predicted. Two other interface loops, loop-1 and loop-4, which contain the active site residues Lys13 and His95, respectively, show significant changes in structure in monoTIM compared with dimeric wild-type TIM.
CONCLUSION: The observed structural differences between monoTIM and wild-type TIM indicate that the dimeric appearance of TIM determines the location and conformation of two of the four catalytic residues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 16100954     DOI: 10.1016/0969-2126(93)90021-8

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  14 in total

1.  Disruption of the aldolase A tetramer into catalytically active monomers.

Authors:  P T Beernink; D R Tolan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

2.  Identification of the Serratia endonuclease dimer: structural basis and implications for catalysis.

Authors:  M D Miller; K L Krause
Journal:  Protein Sci       Date:  1996-01       Impact factor: 6.725

3.  Active site properties of monomeric triosephosphate isomerase (monoTIM) as deduced from mutational and structural studies.

Authors:  W Schliebs; N Thanki; R Eritja; R Wierenga
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

4.  Crystal structures of two monomeric triosephosphate isomerase variants identified via a directed-evolution protocol selecting for L-arabinose isomerase activity.

Authors:  Mirja Krause; Tiila Riikka Kiema; Peter Neubauer; Rik K Wierenga
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-05-23       Impact factor: 1.056

5.  Wildtype and engineered monomeric triosephosphate isomerase from Trypanosoma brucei: partitioning of reaction intermediates in D2O and activation by phosphite dianion.

Authors:  M Merced Malabanan; Maybelle K Go; Tina L Amyes; John P Richard
Journal:  Biochemistry       Date:  2011-06-06       Impact factor: 3.162

Review 6.  Triosephosphate isomerase: a highly evolved biocatalyst.

Authors:  R K Wierenga; E G Kapetaniou; R Venkatesan
Journal:  Cell Mol Life Sci       Date:  2010-08-07       Impact factor: 9.261

7.  Dissection of the gene of the bifunctional PGK-TIM fusion protein from the hyperthermophilic bacterium Thermotoga maritima: design and characterization of the separate triosephosphate isomerase.

Authors:  N Beaucamp; A Hofmann; B Kellerer; R Jaenicke
Journal:  Protein Sci       Date:  1997-10       Impact factor: 6.725

8.  Reflections on the catalytic power of a TIM-barrel.

Authors:  John P Richard; Xiang Zhai; M Merced Malabanan
Journal:  Bioorg Chem       Date:  2014-07-11       Impact factor: 5.275

9.  Design, creation, and characterization of a stable, monomeric triosephosphate isomerase.

Authors:  T V Borchert; R Abagyan; R Jaenicke; R K Wierenga
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

10.  Three-dimensional structure of 6-pyruvoyl tetrahydropterin synthase, an enzyme involved in tetrahydrobiopterin biosynthesis.

Authors:  H Nar; R Huber; C W Heizmann; B Thöny; D Bürgisser
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.